Holen Sie sich die Stockscreener-App
205.59
4.30%
7.74
Schlusskurs vom Vortag:
$197.85
Offen:
$197.94
24-Stunden-Volumen:
433.73K
Relative Volume:
1.26
Marktkapitalisierung:
$5.94B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
68.76
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
+8.81%
1M Leistung:
+12.54%
6M Leistung:
+24.19%
1J Leistung:
+20.78%
1-Tages-Spanne:
$195.47
$212.98
1-Wochen-Bereich:
$183.26
$212.98
52-Wochen-Spanne:
$122.80
$212.98
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
205.39 | 5.73B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.22 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.22 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.73 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.59 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
KRYS: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Krystal Biotech stock hits 52-week high at 208.29 USD - Investing.com
Krystal Biotech (KRYS) Receives Updated Analyst Price Target | K - GuruFocus
Krystal Biotech (NASDAQ:KRYS) Announces Quarterly Earnings Results - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2025 Earnings Call Transcript - Insider Monkey
Will Krystal Biotech Inc. see short term momentumQuarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com
Can Krystal Biotech Inc. hit a new high this monthJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
How Krystal Biotech Inc. (4KB) stock trades under stagflationJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
Will Krystal Biotech Inc. (4KB) stock issue positive guidanceGold Moves & Reliable Entry Point Alerts - newser.com
Tick level data insight on Krystal Biotech Inc. volatilityQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
Decoding Krystal Biotech Inc (KRYS): A Strategic SWOT Insight - GuruFocus
Krystal Biotech Reports Strong Q3 2025 Performance - TipRanks
What valuation multiples suggest for Krystal Biotech Inc. stockPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Krystal's Q3: Platform Designation Adds Pipeline Leverage As Vyjuvek Scales (Rating Upgrade) - Seeking Alpha
Krystal Biotech Inc (KRYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Global ... - Yahoo Finance
Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration - MSN
Krystal Biotech Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Transcript : Krystal Biotech, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript - AOL.com
Is Krystal Biotech Inc. stock gaining market shareJuly 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
What macro factors could drive Krystal Biotech Inc. (4KB) stock higher2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Earnings call transcript: Krystal Biotech Q3 2025 beats EPS forecasts, shares dip - Investing.com
Why Krystal Biotech Inc. stock is recommended by analystsTrade Signal Summary & Technical Pattern Alert System - newser.com
Krystal Biotech’s Profits Rose As Vyjuvek Reached New Markets - Finimize
Krystal Biotech (KRYS) Projects Significant Expenses for FY25 - GuruFocus
Krystal Biotech Inc Surpasses Q3 Estimates with $2.74 EPS and $97.8 Million Revenue - GuruFocus
Why retail investors favor Krystal Biotech Inc. stockTrade Entry Summary & Verified Short-Term Trading Plans - newser.com
Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95 - MarketScreener
Earnings Flash (KRYS) Krystal Biotech, Inc. Reports Q3 Revenue $97.8M, vs. FactSet Est of $93.2M - MarketScreener
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results - The Manila Times
Krystal Biotech, Inc. SEC 10-Q Report - TradingView
Krystal Biotech Q3 net income triples - TradingView
Will breakout in Krystal Biotech Inc. lead to full recovery2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
Torray Investment Partners LLC Makes New $1.59 Million Investment in Krystal Biotech, Inc. $KRYS - MarketBeat
Analyzing Krystal Biotech Inc. with multi timeframe chartsJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
How to integrate Krystal Biotech Inc. into portfolio analysis toolsTrade Risk Assessment & Daily Entry Point Trade Alerts - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streamsJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Institutional scanner results for Krystal Biotech Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Krystal Biotech Inc. stock a safe buy before earningsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Should you hold or exit Krystal Biotech Inc. nowMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):